Sir,

Bone metastases from stomach cancer relates closely to poorly differentiated adenocarcinoma and has a tendency to occur in people with high lymph node involvement. Recurrence more that 8 years after surgery is extremely rare.\[[@ref1][@ref2]\] Here, we present a case of bone metastasis occurring after 8 years of surgery.

A 68-year-old woman was admitted with a 4-month history of diffuse lower back pain and weight loss. Eight years ago, she was diagnosed as having gastric adenocarcinoma poorly differentiated with areas of signet ring cell carcinoma \[[Figure 1a](#F1){ref-type="fig"}\]. Twenty-six lymph nodes were examined, of which 16 were found metastatic; she then underwent total gastrectomy, but no complementary chemotherapy was administered. She was under surveillance for 8 years, which includes abdominal ultrasound, chest X-ray, blood count, liver function test; tumor markers \[carcinoembryonic antigen (CEA), Ca 19.9\] were normal, with apparent remission.

![(a) Histology of primary tumor showing poorly differentiated adenocarcinoma with signet ring cells, and (b) bone marrow biopsy showing poorly differentiated adenocarcinoma with signet ring cells](SJG-17-423-g001){#F1}

Physical examination yielded normal results. Laboratory studies showed the following findings: Hb 9 g/dl; white blood cell count, 6,500/*μ*L; platelets, 87,000 *μ*/L; lactate dehydrogenase (LDH), 578 U/L; alkaline phosphatase, 1,350 U/L; CEA, 7.1 ng/mL; and Ca 19.9, 1,580 U/ml.

Computed tomography (CT) scan of the chest and abdomen, and lumbar magnetic resonance imaging (MRI) showed multiple mixed osteolytic-osteoblastic lesion on the lumbar spine and pelvis without evidence of extra-osseous metastasis. Transiliac bone biopsy revealed an infiltrating adenocarcinoma poorly differentiated with signet ring cell \[[Figure 1b](#F1){ref-type="fig"}\].

The outcome was unfavorable, chemotherapy was discarded, and the patient died 2 months after diagnosis.

Metastasis to the bone from gastric tumors is rare and has been estimated to appear in 1.2%-13.4% of the cases. The difference depends on whether the observation were clinical or at autopsy,\[[@ref3][@ref4]\] and are a late complication occurring years after total removal of primary tumor. These are usually osteolytic or, less commonly, mixed osteolytic--osteoclastic; diffuse osteoblastic lesion may be an unusual feature of this tumor. Thoracic and lumbar vertebrae are the most frequent sites of bone metastases.\[[@ref4]\]

Main symptoms of metastasis are pain (70%), fractures (8.5%), and paraplegia (8.5), but 21% of the cases are asymptomatic.\[[@ref3]\] Laboratory tests showed normocytic, normochromic anemia, thrombocytopenia, and increased levels of serum alkaline phosphatase and Ca 19.9. Bone marrow aspiration and biopsy provide the evidence of malignancy.\[[@ref1][@ref4]\]

Prognosis of patients with osseous metastasis is not good and the median survival time is about 5 months after appearance of symptoms. Radiotherapy has been advocated as the best therapeutic alternative for pain control, with a response rate of 75%, and chemotherapy with 5-fluorouracil (5-FU) have been employed. Nevertheless, prognosis remains poor and therapy is mainly aimed at relieving pain and discomfort.\[[@ref4]\]
